期刊文献+

老年退行性心脏瓣膜病的相关危险因素分析 被引量:6

Risk factors of senile degenerative valvular heart disease
原文传递
导出
摘要 目的探讨老年退行性心脏瓣膜病患者的临床特点及相关危险因素,为老年退行性心脏瓣膜病的早期预防干预提供临床依据。方法收集2022年1月至2022年6月于我院住院的1568例≥60岁老年患者的临床资料,比较退行性心脏瓣膜病组和非退行性心脏瓣膜病组患者的临床特点并分析其危险因素。结果年龄(每增加10岁)(OR=2.107,95%CI=1.518~2.924)、血钙(OR=8.934,95%CI=2.023~39.447)、总胆固醇(OR=1.167,95%CI=1.044~1.304)、女性(OR=2.098,95%CI=1.305~3.374)、平均血小板体积(MPV)降低(OR=0.818,95%CI=0.682~0.981)是影响老年退行性心脏瓣膜病发生的独立危险因素(P<0.05)。两两比较显示:不同钙化程度均与年龄相关(P<0.05);无钙化组载脂蛋白A、尿酸、血磷、游离三碘甲状腺原氨酸与对照组相比差异有统计学意义(P<0.05);中度钙化组二尖瓣舒张早期血流流速峰值与二尖瓣环舒张早期运动速度峰值比值(E/e′)、N端脑钠肽前体与对照组相比有统计学意义(P<0.05);无钙化组和轻度钙化组总胆固醇与对照组相比有统计学意义(P<0.05)。结论年龄、血钙、总胆固醇、女性、MPV降低是老年退行性心脏瓣膜病的独立危险因素。 Objective To explore the clinical characteristics and related risk factors of senile degenerative valvular heart disease(SDHVD),and to provide clinical basis for early prevention intervention of SDHVD.Methods Clinical data of 1568 elderly patients≥60 years old hospitalized in our hospital from January 2022 to June 2022 were collected to compare the clinical characteristics and analyze the risk factors of patients in the degenerative heart valve disease group and the non-degenerative heart valve disease group.Results Age(per 10-year increase)(OR=2.107,95%CI=1.518-2.924),blood calcium(OR=8.934,95%CI=2.023-39.447),total cholesterol(OR=1.167,95%CI=1.044-1.304),female(OR=2.098,95%CI=1.305-3.374),and reduced mean platelet volume(MPV)(OR=0.818,95%CI=0.682-0.981)were independent risk factors for the development of SDHVD(P<0.05).Post hoc two-by-two comparisons showed that different degrees of calcification were associated with age(P<0.05);apoA,UA,P,and FT3 were statistically significant in the no-calcification group compared with the control group(P<0.05);E/e′,PASP,and NT-ProBNP were statistically significant in the moderate calcification group compared with the control group(P<0.05);TC was statistically significant in the no-calcification and mild calcification groups compared with the control group There was statistical significance(P<0.05)compared with the control group.Conclusions Age,blood calcium,total cholesterol,female,and reduced MPV are independent risk factors for SDHVD.
作者 于文华 刘玉娟 于瑶 刘佳 王珊 胡松 毛拥军 Yu Wenhua;Liu Yujuan;Yu Yao;Liu Jia;Wang Shan;Hu Song;Mao Yongjun(Department of Geriatrics,the Affiliated Hospital of Qingdao University,Qingdao 266000 China;Department of Nutrition,Women and Children's Hospital Affiliated to Qingdao University,Qingdao 266000 China)
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2022年第12期1468-1472,共5页 Chinese Journal of Geriatrics
关键词 心脏瓣膜疾病 年龄因素 危险因素 Heart valve diseases Age factors Risk factors
  • 相关文献

参考文献4

二级参考文献91

  • 1龚林(综述),胡阳,邓洁(审校).血流动力学对主动脉瓣钙化的影响[J].医学信息(医学与计算机应用),2014,0(14):638-639. 被引量:1
  • 2Ferreira-Gonzlez I,Pinar-Sopena J,Ribera A,et al.Prevalence of calcific aortic valve disease in the elderly and associated risk factors:apopulation-based study in a Mediterranean area.Eur J Prev Cardiol,2013,20:1022-1030.
  • 3Go AS,Mozaffarian D,Roger VL,et al.Executive summary:heart disease and stroke statistics--2014update:a report from the American Heart Association.Circulation,2014,129:399-410.
  • 4Rosseb? AB,Pedersen TR,Boman K,et al.Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.N Engl J Med,2008,359:1343-1356.
  • 5Chan KL,Teo K,Dumensil JG,et al.Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis:results of the aortic stenosis progression observation:measuring effects of rosuvastatin(ASTRONOMER)trial.Circulation,2010,121:306-314.
  • 6Rajamannan NM,Evans FJ,Aikawa E,et al.Calcific aortic valve disease:not simply a degenerative process:A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group.Executive summary:Calcific aortic valve disease-2011 update.Circulation,2011,124:1783-1791.
  • 7Owens DS,Katz R,Takasu J,et al.Incidence and progression of aortic valve calcium in the Multi-ethnic Study of Atherosclerosis(MESA).Am J Cardiol,2010,105:701-708.
  • 8Rossi A,Faggiano P,Amado AE,et al.Aortic valve sclerosis is a marker of atherosclerosis independently of traditional clinical risk factors.Analysis in 712patients without ischemic heart disease.Int J Cardiol,2012,158:163-164.
  • 9Gould ST,Srigunapalan S,Simmons CA,et al.Hemodynamic and cellular response feedback in calcific aortic valve disease.Circ Res,2013,113:186-197.
  • 10Paul A. Gurbel,Kevin P. Bliden,Waiel Samara,Jason A. Yoho,Kevin Hayes,Mulugeta Z. Fissha,Udaya S. Tantry.Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis[J]. Journal of the American College of Cardiology . 2005 (10)

共引文献148

同被引文献91

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部